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Double minutes (dmin)—circular, extra-chromosomal amplifications of specific acentric DNA fragments—
are relatively frequent in malignant disorders, particularly in solid tumors. In acute myeloid leukemia
(AML) and myelodysplastic syndromes (MDS), dmin are observed in 1% of the cases. Most of them con-
sist of an amplified segment from chromosome band 8q24, always including the MYC gene. Besides this
information, little is known about their internal structure. We have characterized in detail the genomic
organization of 32 AML and two MDS cases with MYC-containing dmin. The minimally amplified region
was shown to be 4.26 Mb in size, harboring five known genes, with the proximal and the distal amplicon
breakpoints clustering in two regions of 500 and 600 kb, respectively. Interestingly, in 23 (68%) of the
studied cases, the amplified region was deleted in one of the chromosome 8 homologs at 8q24, suggesting
excision of a DNA segment from the original chromosomal location according to the ‘episome model’. In
one case, sequencing of both the dmin and del(8q) junctions was achieved and provided definitive evi-
dence in favor of the episome model for the formation of dmin. Expression status of the TRIB1 and
MYC genes, encompassed by the minimally amplified region, was assessed by northern blot analysis.
The TRIB1 gene was found over-expressed in only a subset of the AML/MDS cases, whereas MYC, contrary
to expectations, was always silent. The present study, therefore, strongly suggests that MYC is not the
target gene of the 8q24 amplifications.
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INTRODUCTION
Double minutes (dmin)—the cytogenetic hallmark of
extra-chromosomal genomic amplification—are small,
paired, acentric chromatin bodies [(1) and references
therein]. Different hypotheses have been proposed to
explain how these circular structures, at times reaching
several megabases in size, arise (2–4). In one model, the
dmin, as well as the related homogeneously staining region
(hsr) formation, is thought to be generated as a consequence
of breakage-fusion-bridge cycles (5). An alternative proposed
mechanism is the ‘deletion-plus-episome’ model (also known
as ‘episome model’) (6–11), which postulates that DNA seg-
ments are excised from the chromosome, circularized and
amplified by mutual recombination to produce dmin, or inte-
grated into chromosomes to generate hsr. Data in support for
this hypothesis have reported interstitial deletions of genes
corresponding to the ones amplified in the dmin (12–16).
Furthermore, episomes that gradually enlarge to dmin, with
concomitant deletions, have been documented in Chinese
hamster ovary cells (6) and in human neuroblastoma cell
lines (17). In other instances, however, no deletions corre-
sponding to the amplified chromosomal sequences were
detected (18–21).
In order to clarify the mechanisms underlying the for-
mation of dmin, we have performed a detailed genomic
analysis of 34 acute myeloid leukemia (AML)/myelodys-
plastic syndrome (MDS) cases with MYC-containing dmin,
using fluorescence in situ hybridization (FISH) and, when
possible, quantitative polymerase chain reaction (PCR),
junction sequencing and northern blot expression status of
candidate genes in the amplified region. The results clearly
supported the excision episome model for dmin genesis
and strongly suggest that MYC is not the target gene of
the amplification.
RESULTS
Clinical and cytogenetic features of the 34 AML/MDS
cases are summarized in Supplementary Material,
Table S1. FISH analysis with appropriate probes showed
that dmin had large inter- and intra-individual size vari-
ation, and that the amplified MYC region was occasionally
present both as extra-chromosomal dmin and intra-
chromosomal hsr (Supplementary Material, Fig. S1). In 23
(68%) of 34 cases, the MYC probe did not hybridize to
one of the chromosome 8 homologues (Supplementary
Material, Table S1), indicating an accompanying submicro-
scopic deletion of the corresponding 8q24 segment; no del-
etions were observed in the remaining 11 (32%) cases
(Supplementary Material, Figs S1 and S2). In two del(8q)
cases (13 and 26), the deletion was observed in only a sub-
population of cells with MYC-containing dmin (12 and
96%, respectively), indicating the presence of two different
clones with MYC amplification; these clones are referred to
as ‘a’ (major clone) and ‘b’ (minor clone) (Supplementary
Material, Fig. S1B). Additional chromosome 8 rearrange-
ments further differentiating the ‘deleted’ and ‘non-deleted’
clones were identified in these two cases (Supplementary
Material, Figs S1 and S2).
Sizes of the amplicons and interstitial deletions
In order to map precisely the proximal (PB) and distal (DB)
breakpoints of the amplified genomic segments in the dmin,
we utilized panels of bacterial artificial chromosome (BAC)
clones (Fig. 1) selected according to the UCSC database
(http://genome.ucsc.edu). In each dmin-positive case, reiterat-
ive FISH experiments were performed to identify BAC clones
encompassing the breakpoints. These clones were identified if:
(i) they consistently yielded fainter FISH signals on the dmin
when compared with the signals on the normal chromosome(s)
8; (ii) the partially-overlapping proximal and distal clones
yielded opposite results (negative or positive) on dmin; and
(iii) these results were consistent with the position of PB or
DB. The overall results are summarized in Figure 1 (examples
in Supplementary Material, Fig. S2). The PBs mapped within
an interval of 500 kb (from 126 000 000 to 126 500 000) in
33 cases (97%) (Fig. 1A). In case 26, the two different clones
with dmin [26a with del(8q) and 26b without del(8q)] dis-
played different PBs. The DBs were scattered within a
3.7 Mb region (from 130 760 000 to 134 440 000), with
most breakpoints (86%) within a 600 kb interval (from
130 760 000 to 131 360 000) (Fig. 1B). Cases 26, 30 and 32
harbored two subpopulations with different DBs. The ampli-
cons in cases 29 and 32 were discontinuous, with both cases
showing similar internal deletions, delineated by the clones
RP11-976L13 and RP11-1146N6 (data not shown), a finding
observed in only these two of 34 analyzed cases. By FISH
mapping (Figs 1 and 2), the size of the amplicons varied
from 4.29 Mb (case 8) to 7.83 Mb (case 9), with a commonly
amplified segment of 4.26 Mb, harboring five known genes
[from cen to tel: TRIB1, NSE2, AF268618, MYC and
AK093424 (Fig. 2)].
In 14 (61%) of 23 cases with 8q24 deletions (Supplemen-
tary Material, Table S1), the del(8q) corresponded with the
amplified segments on the dmin by FISH studies (Fig. 2).
This conclusion was based on the observation that: (i) the
same BAC clone displayed a fainter signal on both the
dmin and the del(8q) or on the derivative chromosomes in
cases 13, 26 and 27 (Supplementary Material, Fig. S2A,
SD–SF); and (ii) the flanking clones on both the dmin and
the del(8q) showed consistent results. These data strongly
indicate dmin formation by excision. In the remaining nine
cases (39%), the deletions were larger than the corresponding
amplified segment (Fig. 2 and Supplementary Material,
Fig. S2B).
In 13 cases, real-time PCR experiments indicated 17- to
45-fold increases in MYC copy number (Supplementary
Material, Fig. S3). Additional real-time PCR experiments,
aimed at ascertaining the size of the amplified genomic
segment (cases 2, 4, 8, 17, 18, 19, 23, 26 and 29), were in
perfect agreement with the FISH results in all nine cases.
Cloning of the junction regions
Using forward and reverse primers designed on the distal and
proximal amplicon borders and oriented towards the junction,
the dmin junctions were successfully amplified in five cases
(cases 2, 8, 18, 19 and 23) by long-range PCR experiments
and nested PCR experiments were used to sequence the
934 Human Molecular Genetics, 2006, Vol. 15, No. 6
fusion regions (Fig. 3). These results clearly indicate a
‘head-to-tail’ arrangement of the amplicons. In addition, a
single PCR product was obtained in all cases, suggesting,
within the limits of agarose gel analysis, that the junction
regions were not heterogeneous. Several attempts were made
to clone the junction region of the deleted chromosome 8 in
cases 18, 23, 26 and 29. Case 18 was the only case in which
both dmin and deletion junctions were successfully amplified
(Fig. 4). No PCR products were obtained in cases 4, 17, 26 and
29, although Southern blot analyses confirmed rearrangements
of the intervals encompassing the DB identified by FISH and
real-time PCR (data not shown) in cases 4 and 17. Vectorette
PCR analyses, aimed at cloning the dmin junctions in cases 4,
17, 26 and 29, failed (data not shown).
Three of the 12 junctions (Fig. 3) were located within SINEs,
including Alu (PB in case 2) and mammalian interspersed repeat
(MIR) elements (PB and DB in case 23). The PB in both the
del(8q) and the dmin in case 18 (Fig. 4) were mapped within a
human self-chain alignment region (a region of the human
genome where multiple DNA chains align). All other break-
points were located within single copy sequences. Taken
together, these results indicated that homologous recombination
(HR) could have triggered a circularization event between two
SINE (MIR) elements in only one case (case 23). Sequence
analysis of the dmin junctions in cases 2 and 8 revealed a circu-
larization event accompanied by an insertion of six and 19 nt,
respectively; in addition, the insertion in case 8 contained a
partial duplication of a 15 nt sequence flanking the breakpoint
(Fig. 3). Non-homologous end-joining (NHEJ) micro-
homologies of two nt (CT) and four nt (ATTT) were detected
at the amplicon junctions in cases 18 and 23. A two nt (AT)
microhomology was also found at the deletion junction in
case 18. Case 19 had an ‘end-to-end’ fusion between the
proximal and the distal ends of the amplicon.
Interestingly, the PB and DB of the del(8)(q24q24) in case
18 were mapped 230 and 40 bp proximal to the PB and DB,
respectively, of the amplicon (Fig. 4).
Bioinformatic analysis
GenAlyzer analysis did not reveal any extensive similar
sequences in the chromosome 8 regions containing the PB
and DB that could trigger a chromosome rearrangement result-
ing in dmin formation (data not shown). Consequently, we
searched for other genomic properties of the target regions
that might explain the clustering of the PB and DB. The
results of the MAR-Wiz analyses are summarized in Sup-
plementary Material, Fig. S4. The PB and DB cluster
regions were located in two regions of low and infrequent
matrix attachment region (MAR) potential. The proximal
region contained three genes (ZNF572, KIAA0196 and
FLJ324440) within a 500 kb sequence and the distal region
contained three genes (MLZE, FAM49B and DDEF1) within
a 600 kb sequence, i.e. a gene density of one gene/167 kb
and one gene/200 kb, respectively. The deleted/amplified
region, on the other hand, contains only five known genes
within a 4.3 Mb segment, i.e. a gene density of one gene/
860 kb. Furthermore, the breakpoint cluster regions were
shown to be poor in inter-genic, non-coding DNA, with the
included genes being large and containing many exons,
whereas the amplified region was found to be mainly non-
coding, containing small genes with 1–3 exons. Thus,
the PB and DB cluster regions are poor in MARs and rich
in genes.
Figure 1. Distribution of the PB (A) and DB (B) of the amplicons and location of the PB (A) and DB (B) cluster regions in the 34 AML/MDS cases with
MYC-containing dmin. Cases with or without accompanying 8q24 deletions (Supplementary Material, Table S1) are denoted in blue and red, respectively.
Case 26 had two different cell populations—with (26a, blue) and without (26b, red) del(8)(q24q24)—with different PB and DB. The location of the BAC/
PAC clones and the genes in the region are shown in brown and blue, respectively. Their positions were derived from the UCSC Genome Browser (http://
genome.ucsc.edu/cgi-bin/hgGateway?DB ¼ hg17; May 2004 release). In (B), cases 30 and 32 are shown twice because they had two different cell populations,
with distinct DB, ‘a’ and ‘b’, respectively.
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Over-expression of TRIB1 but not of MYC
Northern blot analyses of cases 6, 7, 8, 11, 12, 23, 27, 32 and
33 revealed over-expression of TRIB1, compared with AML
and MDS cases without dmin or þ8, in two of them (23 and
27), and a slight increase in case 6. Over-expression of MYC
was not observed in any of these cases (Fig. 5). We have
also searched for the presence of miRNAs in the amplified
region, but no experimentally validated miRNAs were found
(UCSC database http://genome.ucsc.edu).
DISCUSSION
In the present study, 34 AML/MDS cases with 8q24/MYC
amplifications in the form of dmin (32 cases) or hsr (two
cases) were analyzed in detail. Our results can be summarized
as follows: (i) deletions corresponding to, or larger than, the
amplicons were predominant (68%), suggesting post-
replicative excision of circular DNA (episome) as the mechan-
ism behind the dmin formation; (ii) the commonly amplified
segment was 4.26 Mb in size and included four known
genes in addition to MYC; (iii) even though the gene copy
number of MYC was increased up to 45-fold, the gene was
not over-expressed; (iv) the TRIB1 gene was over-expressed
in a subset of the cases; (v) the PB of the amplicons clustered
within a 500 kb region in all but one case, whereas the DB
clustered within a 600 kb region in 86% of cases; (vi) the
circularization event of the amplicon appears consistent with
error-prone NHEJ rather than mediated by HR; and (vii) the
PB and DB cluster regions correspond to chromosomal seg-
ments with fewer MARs and more genes than the amplicons.
Expression studies
Detailed FISH mapping identified a commonly amplified
4.26 Mb genomic segment harboring five known genes
[from cen to tel: TRIB1, NSE2, AF268618, MYC and
AK093424; Fig. 2]. In a previous, two-case, investigation of
MYC-containing dmin in AML/MDS, northern blot analyses
showed no expression of AK093424, low expression of
MYC, normal expression of NSE2 and AF268618, with over-
expression of TRIB1, suggesting that TRIB1, not MYC, was
the most likely amplified target gene (22). The present study
adds further support to the exclusion of MYC as the target
gene, despite the fact that its copy number was increased
17- to 45-fold (Fig. 5 and Supplementary Material, Fig. S3)
and further suggests that TRIB1, with over-expression in just
two cases 23 and 27 (Fig. 5), may not be the critical gene
either; however, a potential role for MYC at tumor initiation or
early progression cannot be categorically excluded. Examples
of discrepant gene copy number and expression levels have
been reported in literature (23–25). Similarly, other un-
detected mutation(s), elsewhere in the genome, cannot be
excluded as well. Regardless, dmins persistence, despite
Figure 2. Sizes, as defined by FISH, of the amplifications (red) and deletions (blue) in the 23 cases with del(8)(q24q24). Case numbers (Supplementary Material,
Table S1) are at the top of the figure. The five known genes within the commonly amplified segment are derived from the UCSC Genome Browser (May 2004
release; http://genome.ucsc.edu/cgi-bin/hgGateway?DB¼hg17) and are denoted in red. Genes mapping outside, but in the vicinity of, the commonly amplified
segment are denoted in blue.
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their intrinsic mitotic instability, strongly supports a prolifer-
ation advantage role for dmin.
Excision model
The majority (68%) of investigated cases harbored interstitial
8q24 deletions corresponding to the amplicons. Similar del-
etions have been reported in AML and MDS with MYC-
containing dmin (12,22,26–30), MLL amplification (13),
NUP214/ABL1-positive hematologic malignancies (15),
HMGA2/MDM2- (14) and MYC/ATBF1-positive solid tumors
(16). The latter authors have characterized in detail a
complex translocation-excision-deletion-amplification in a
neuroblastoma cell line, involving the MYC gene. The
amplified 8q24 region (127 865 985 to 128 406 810 bp) was
definitely smaller (541 kb) in comparison with the minimal
interval we have reported (4.26 Mb). The deletion encom-
passed the region 127 865 985–130 479 097 bp (2.6 Mb).
A novel finding in the present study was the remarkable
agreement, at the molecular cytogenetic level, of the deletions
and amplicons. This observation and the integration of excised
segments into various chromosomes (hsr formation), followed
by intra-chromosomal amplification, as observed in cases 10
and 14, is most consistent with a mechanism of excision,
circularization and subsequent amplification or the episome
model (6,9). The finding that 11 (32%) cases did not show a
concomitant del(8)(q24q24) does not oppose this conclusion:
it may only indicate that the excision event was post-
replicative. The circular element may segregate randomly
with either normal or del(8q). Conversely, it is also possible
that the deletions subsequently were ‘corrected’ as a result
of somatic recombination between the two chromosome 8
homologues, a possibility consistent with the high frequency
of partial uniparental disomies recently reported in AML
(31,32). The present finding of two separate dmin-carrying
populations—with and without del(8q)—in cases 13 and 26
would agree with both these possibilities.
Dmin breakpoint properties
Because the vast majority of PB and DB grouped together
within two ‘breakpoint cluster regions’ (Fig. 1), a search of
Figure 3. Sequences of the junctions of the amplicons in cases 2, 8, 18, 19 and
23 (A) and of the del(8)(q24q24) in case 18 (B). The junction sequences are
aligned with the corresponding normal chromosome 8 sequences. Inserted
nucleotides as well as microhomologies in the junctions are indicated in
bold and in italics, respectively. Duplications of nucleotides within the dmin
junction in case 8 are underlined. The numbers indicate the position at nucleo-
tide level on the sequence of chromosome 8 according to the UCSC database,
using the BLAT tool (http://genome.ucsc.edu/cgi-bin/hgBlat).
Figure 4. Schematic representation and sequences of the breakpoint regions of
the del(8q) and of the amplicon in case 18. The red and blue nucleotides/bars
indicate amplification and deletion borders, respectively. The ‘black’ nucleo-
tides of the PB are deleted on the del(8q) but not amplified on the dmin,
whereas the ‘green’ nucleotides of the DB are amplified on the dmin but
not deleted on the del(8q).
Figure 5. Northern blot analyses of TRIB1 and MYC showing over-expression
of TRIB1 in cases 23 and 27, and a slight increase in case 6. In none of the
cases was over-expression of MYC detected. b-Actin was used to verify
successful transfer of the varying amounts (2–5 mg) of RNA available. C1
and C2 represent control RNA (10 mg) from one case of AML and MDS,
respectively, without dmin or þ8.
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fragile sites in these regions was undertaken. Two
aphidicolin-inducible common fragile sites map within band
8q24. In fact, FRA8C (chr8:124,236,796–128,490,427) (33)
spans the proximal region, whereas FRA8D (34) may span
the distal region; this fragile site is known to start at
chr8:129,026,266 (1.7 Mb proximal to the distal region) but
its extension has, as yet, not been ascertained. Thus,
common fragile sites may overlap with both breakpoint
cluster regions identified in this study. However, size differ-
ences, i.e. 4 Mb of FRA8C versus 500 kb of the PB cluster
region, and the elusive nature of aphidicolin-inducible
fragile sites make it difficult to conclude that these fragile
sites were involved in the genesis of the dmin. Considering
that the dmin contained the MYC, the gene targeted by trans-
locations in Burkitt lymphoma (BL), T-cell acute lymphocytic
leukemia (T-ALL) and multiple myeloma (MM), it is tempting
to speculate that the 8q24/MYC region is prone to chromo-
somal breakage and rearrangement. However, it should be
stressed that the translocation breakpoints in BL and MM
are located very close, within 1 Mb proximally and distally,
to the MYC gene (34,35), whereas the PB and DB cluster
regions in the dmin map 2 Mb proximally and distally to MYC.
Molecular cloning and sequencing of the amplicon junc-
tions in five cases showed that the amplicon breakpoints
were located in non-homologous genomic regions (Fig. 3); a
finding not consistent with a circularization event triggered
by HR pairing between repeated sequences. Only case 23
showed amplicon junctions within a SINE (MIR) element.
In higher eukaryotes, NHEJ—an alternative
mechanism to error-free HR—has evolved to maintain
genomic integrity after induction of DNA double-strand
breaks (DSB) (36,37), which may occur after exposure to
ionizing radiation and DNA topoisomerase II inhibitors,
well-known agents associated with leukemogenesis (37,38).
Conversely, error-prone NHEJ has been suggested to be
involved in the generation of chromosome rearrangements,
including deletions and translocations (39), and in many
instances this repair process occurs at free ends showing
either microhomologies of a few nucleotides or at ends
displaying no homologies (40).
Vogt et al. (41) reported fusion of the amplicon ends
mediated by microhomology-based NHEJ in six of seven
dmin-carrying gliomas cases. In the present study, sequencing
of the amplicon junctions showed nucleotide microhomologies
in two of five cases (cases 18 and 23); the remaining three
cases either displayed a blunt junction (19) or had insertions
at the junctions (2 and 8) (Fig. 3). In case 8, 15/19 inserted
nt corresponded to a partial duplication of the sequence flank-
ing the DB, whereas the five nt segment inserted at the junc-
tion in case 2 was of unknown origin. Taken together, these
results show that microhomology-based NHEJ is not the
only mechanism involved in the fusing of the free ends of
dmin. Furthermore, the failure to clone the junctions in
cases 17, 19, 26 and 29 may indicate that the genomic archi-
tecture at the ends of the amplicons in these cases was even
more complex, for example large insertions or heterogeneous
amplicons sizes (cases 26 and 29), than in those that could be
analyzed. In case 18, the junction on the del(8)(q24q24) was
in agreement with the sequence junction of the amplicon,
i.e. the PB and DB of the deletion-mapped 230 and 40 nt,
respectively, centromeric to the PB and the DB of the
amplicon. Thus, the amplified and deleted segment was
identical except for a 230 nt proximal gap and a small 40 nt
distal overlap (Fig. 4), the latter of which may be explained
by the fill-in of the protruding single strand ends generated
at DSB (42). In this case both the deletion and amplicon junc-
tions were the result of a 2 nt microhomology-based NHEJ.
Because low copy repeat regions have been reported to play
an important role in triggering inter- and intra-chromosomal
HR in neoplasia-associated chromosomal abnormalities, such
as t(9;22)(q34;q11.2) in chronic myeloid leukemia (CML)
(43) and i(17)(q10) in AML, CML and MDS (44), a search
for low copy chromosome 8 repeats surrounding the entire
amplicon was performed (UCSC database, WSSD Duplication
and Segmental Dups tracks). No intra-chromosomal duplicons
were identified. However, the breakpoint cluster regions had
fewer MARs but more genes than the amplicons (Supplemen-
tary Material, Fig. S4). Although these findings do not agree
with previous results showing co-localization of MAR
elements with the breakpoints in the AML-associated
t(8;21)(q22;q22) (45), in the FRA16B AT-rich island (46),
and in a topoisomerase II sensitive region in Chinese
hamster (45–47), they are in accordance with the study by
Hensel et al. (48) who reported MLL and AFF1 (AF4) break-
points in the ALL-associated t(4;11)(q21;q23) are usually
located outside MARs.
The reason behind the fragility of the two identified break-
point cluster regions could possibly be ascribed to the chroma-
tin status of these regions. Transcribed DNA is less packed
than inactive chromatin, and it is tempting to speculate that
open chromatin is more vulnerable to DNA damage
leading to chromosomal rearrangements (49–51). Considering
that the breakpoint cluster regions harbored more genes than
the amplicons, the former would be expected to have a
higher transcription activity, less condensed chromatin struc-
ture and potentially more sensitive to DNA damage or enzy-
matic cleavage.
Concluding remarks
Although a complete understanding of the amplification pro-
cesses underlying the dmin phenomenon remains a challenge,
the current study provided the first sequence-based evidence
supporting the episome model, and strongly suggests, contrary
to expectations, that the MYC is not the target gene of dmin
amplification.
MATERIALS AND METHODS
Patients
Thirty-four AML/MDS cases with MYC-containing dmin were
collected from 14 different laboratories in Europe, US and
Australia, comprising the largest series of dmin-positive
AML and MDS cases reported to date. Basic clinical and cyto-
genetic features of the patients are listed in Supplementary
Material, Table S1. The median age was 70 years (range 34
and 86 years) with 22 females and 12 males. All but two
patients presented with AML, including 11 unclassified, five
M1, 13 M2, one atypical M3, one M4 and one M5; the two
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remaining cases were unclassified MDS and chronic myelo-
monocytic leukemia, respectively. In eight (24%) patients,
dmin were found as the sole anomaly, eight (24%) additional
cases displayed two karyotypic changes and the remaining 18
(53%) cases were cytogenetically complex.
Molecular cytogenetic analyses
MYC amplification was initially screened by FISH using the
LSI C-MYC probe (Abbott, Rome, Italy), mapping to 8q24,
or with the P1 artificial chromosome (PAC) clone
RP1-80K22 (GenBank accession no. AF315312) covering
the MYC gene. The MYC-containing dmin were then further
characterized and mapped using contigs of BAC and PAC
clones (Fig. 1), at 8q22-24, previously used to identify the
breakpoint regions in 8q24-positive dmin (22). All clones
belonged to the RP1 and RP11 libraries (http://www.chori.
org/bacpac). Whole chromosome painting probes for chromo-
somes 3, 4 and 8 were derived from flow-sorted chromosomes
(generously provided by Dr. Nigel Carter, Sanger Centre,
Cambridge, UK) and amplified by degenerated oligonucleo-
tide probe PCR. The a-satellite probe pZ8.4 (52) was used
to identify the centromeric region of chromosome 8.
Co-hybridization experiments were performed by directly
labeling the BAC/PAC clones with FITC-, Cy3- or
Cy5-conjugated dUTP by nick-translation. Some of the
probes were labeled with biotin–dATP and then detected
with diethylaminocoumarin (DEAC)-conjugated streptavidin.
FISH was performed as previously described (53). Digital
images were obtained using a Leica DM-RXA2 epifluo-
rescence microscope equipped with a cooled CCD camera
(Princeton Instruments, Boston, MA). Cy3 (red), fluorescein
(green), DEAC (blue), Cy5 (infra red) and DAPI (blue) fluo-
rescence signals were detected using specific filters. Images
were separately recorded as gray-scale images. Pseudocolor-
ing and merging of images were performed using the Adobe
Photoshop software. BAC clones that consistently yielded
fainter FISH signals on the dmin, comp.
Multicolor-FISH
M-FISH, used to characterize the 8q24-amplification in the
form of hsr in cases 10 and 29 (Supplementary Material,
Fig. S1C), was performed in accordance with the manufac-
turer’s instructions, using the commercially available
24-colour SpectraVysion probe (Abbott) (54). High-quality
metaphase images were captured using a Leica DM-RXA2
epifluorescence microscope equipped with an eight-position
automated filter wheel and a cooled CCD camera (Princeton
Instruments). Six fluorescent images were captured per meta-
phase using filter combinations specific for SpectrumGold,
SpectrumAqua, SpectrumGreen, FRed, Red and DAPI.
Images were processed using the Leica CW4000 M-FISH
software.
Amplicon analyses
Level of amplification. DNA was available in 13 of the 34
cases. The level of 8q24 (MYC ) amplification in the 13
cases was determined by real-time PCR, with DNA from a
healthy individual as a control. DNA was extracted from
fresh or stored (2808C) bone marrow samples according to
standard methods. The DNA was amplified using the
Applied Biosystems Real-Time PCR System 7300 using the
SYBR Green PCR or the TaqMan PCR kits (Applied Bio-
systems, Monza, Italy). The PCR conditions were as
follows: 2 min at 508C, 10 min at 958C, followed by 40
cycles of 15 s at 958C and 1 min at 608C for all the primer
pairs and probes used. All measurements were performed at
least in triplicate. Primers and probes were designed with
the Primer Expressw software v2.0 (Applied Biosystems).
The primers were selected using the BLAT tool in the
UCSC Human Genome Browser (55) (http://genome.
ucsc.edu/cgi-bin/hgBlat); care was taken to avoid amplifica-
tion of possible homologous sequences in other chromosomal
locations (primer sequences available upon request). The level
of MYC amplification in the dmin was calculated using the
relative quantification approach based on the DDCt method
(56), which calculates the difference between the DNA quan-
tity of the target gene and of the reference gene (RNAseP;
Applied Biosystems) for each sample (DCt). This value was
then compared with the human genomic control DNA
(Applied Biosystems) which is used as a calibrator
(DDCt ¼ DCt sample2 DCt calibrator). The relative quantity
(RQ) of DNA is determined as 2DDCt, with the number of
copies of the target gene in each sample tested being 2  RQ.
Mapping of the dmin junctions at the sequence level. In nine
cases (2, 4, 8, 17, 18, 19, 23, 26 and 29), sufficient amount
of DNA was available for detailed characterization, at the
sequence level, of the PB and DB, respectively of the ampli-
cons. Multiple primer pairs that mapped at 10 kb intervals
within the BAC clones spanning the breakpoints were
designed and used to perform real-time PCR experiments,
using DNA from a healthy individual as a control, in order
to identify regions of switch between amplified and non-
amplified sequences. The 10 kb segment encompassing the
breakpoint was further narrowed down using the same
approach, i.e. by selecting additional primer pairs within that
region.
Junction sequencing. The information derived from the real-
time PCR experiments described earlier, was utilized to
design appropriate forward and reverse primers mapping in
the DB and PB regions and used in long-range PCR experi-
ments, with the aim of sequencing the dmin junction
regions. Furthermore, in cases 18, 23, 26 and 29, the junctions
in the del(8q) were investigated using long-range PCR with
forward and reverse primers selected on the basis of
the sequences flanking the amplicons on the dmin. In case
of positive results, nested PCR experiments were performed.
The long-range PCR analyses were performed using
TaKaRa LA TaqTM (Cambrex Bio Science, Milan, Italy),
and the nested PCR products containing the junction frag-
ments were sequenced using the Big Dye Terminator Sequen-
cing kits (Applied Biosystems). Reference genome sequence
data were obtained from the UCSC browser (http://genome.
ucsc.edu/cgi-bin/hgGateway?db¼hg17; May 2004 release),
and sequence comparison was performed using the BLAST
software tool (www.ncbi.nlm.nih.gov/BLAST/).
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Southern blot analyses. Southern blot analyses (57) were per-
formed on cases 4 and 17 to validate the breakpoint results
obtained by real-time PCR because the long-range PCR exper-
iments, in these two cases, were unsuccessful (see Results). In
brief, 2 mg of DNA from the patients and a healthy control
were digested with BglII and EcoRI (case 4) or HaeIII (case
17) (Roche, Milan, Italy), electrophoresed on 0.5% agarose
gels, and transferred and fixed onto nylon membranes
(Hybond-N, Amersham Pharmacia Biotech, Cleveland, OH)
using standard protocols. The 32P-labeled probes 22distA1
(265 bp) and 19dist2 (400 bp) for cases 4 and 17, respectively,
were generated by PCR amplification using the primers
22distA1 and 19dist2 (primer sequences available upon
request).
Vectorette PCR. Cloning of the dmin junctions was performed
using the Vectorette PCR experiments, using the Universal
VectoretteTM System (Sigma Genosys, Milan, Italy) to, were
performed on cases 4, 17, 26 and 29, in which the long-range
PCR analyses were unsuccessful (see Results). After digestion
of 1 mg DNA with HindIII and EcoRI (Roche) and ligation
with T4 DNA ligase (Sigma Genosys) of the corresponding
Vectorette units to the digested ends of the DNA samples,
Vectorette PCR was performed according the manufacturer’s
protocol (http://www.sigma-genosys.com).
Northern blot analysis
Total RNA from the patients’ bone marrow and control cells
was extracted using the Trizol reagent as described by the
manufacturer (Invitrogen, Stockholm, Sweden). Sufficient
amounts of good quality RNA, between 2 and 5 mg, were
obtained in nine cases. Total RNA were electrophoresed in
1% formaldehyde/formamide gels, blotted as described (58),
and subsequently hybridized with 32P-labeled probes gener-
ated by PCR amplification (primer sequences available upon
request) of the genes investigated. The identity of all probes
was verified by sequencing, using the BigDye mix (Applied
Biosystems, Warrington, UK). The signals were detected by
phosphorimaging. b-Actin was used as a probe to verify
equal loading and successful transfer of RNA. The expression
patterns of TRIB1 and MYC were analyzed. These genes were
chosen because of previous evidence that TRIB1—and not
MYC—may be the target of 8q24 amplifications in hemato-
logic malignancies (22). The NSE2, AF268618 and
AK093424, which also map within the commonly amplified
segment (see Results), were not analyzed because a previous
study showed that these genes were not over-expressed in
AML and MDS with MYC-containing dmin (22).
Bioinformatics and sequence analyses
The chromosome 8 sequences used for bioinformatic analyses
were obtained from the UCSC Genome Browser website
(http://genome.ucsc.edu/cgi-bin/hgGateway?db¼hg17; May
2004 release).
Low copy repeat analysis. Segmental duplications occurring
within an 8 Mb genomic segment (chr 8: 124 550 000–
132 550 000), including the entire 8q24 amplicon, were
searched for using GenAlyzer, a program of the REPuter
family (http://www.genomes.de/) (59), on a sequence down-
loaded from the UCSC website (ftp://hgdownload.cse.ucsc.
edu/).
MARs potential analysis. Putative MARs were mapped by the
use of MAR-Wiz 1.5 (http://www.futuresoft.org/MAR-Wiz/),
which predicts matrix association potential (MAP) using the
following criteria: AT and CG-richness, sequence motifs for
curved and kinked DNA, presence of topoisomerase II recog-
nition sites, and replication origins. Unmasked sequence data
were submitted in 500 kb segments. The default settings for
generating MAPs were used, except the clipping parameter.
The latter value was modified in order to obtain graphs
where the MAPs ranged from 0 to 18. The graphical outputs
of the MAPs were aligned to form a single graph in Adobe
Photoshop CS 8.0. Each peak represents the MAP value of a
1 kb sequence window. According to the MAR-Wiz online
instructions, all the normalized peaks having MAP values
greater than 10.8 (threshold value representing 0.6 times of
the maximum value of 18) should be considered as hypotheti-
cal MARs. High MAP values in three successive windows
strongly suggest the occurrence of a MAR.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
ACKNOWLEDGEMENTS
This work was supported by AIRC (Associazione Italiana per
la Ricerca sul Cancro), FIRC (Fondazione Italiana per la
Ricerca sul Cancro), the European LeukemiaNet (Workpack-
age 11–Cytogenetics), the Swedish Cancer Society and
CA32102. C. Surace is the recipient of a FIRC 3-year fellow-
ship. We are grateful to Dr Cheryl Willman and Dr Richard
Harvey for providing samples 6–9 for this study; Lisa
Robson, Luke St. Heaps, Sara Diaz, for the FISH studies for
cases 1, 5, 16; Dr Vale´rie Parlier and Dr Vale´rie Beyer for
their contribution to the study of cases 11–13, 27, 34.
Conflict of Interest statement. None declared.
REFERENCES
1. Hahn, P.J. (1993) Molecular biology of double-minute chromosomes.
Bioessays, 15, 477–484.
2. Windle, B., Draper, B.W., Yin, Y.X., O’Gorman, S. and Wahl, G.M.
(1991) A central role for chromosome breakage in gene amplification,
deletion formation, and amplicon integration. Genes Dev., 5, 160–174.
3. Masuda, A. and Takahashi, T. (2002) Chromosome instability in human
lung cancers: possible underlying mechanisms and potential consequences
in the pathogenesis. Oncogene, 21, 6884–6897.
4. Stark, G.R. and Wahl, G.M. (1984) Gene amplification. Annu. Rev.
Biochem., 53, 447–491.
5. Mc Clintock, B. (1951) Chromosome organization and genic expression.
Cold Spring Harb. Symp. Quant. Biol., 16, 13–47.
6. Carroll, S.M., DeRose, M.L., Gaudray, P., Moore, C.M.,
Needham-Vandevanter, D.R., Von Hoff, D.D. and Wahl, G.M. (1988)
Double minute chromosomes can be produced from precursors derived
from a chromosomal deletion. Mol. Cell. Biol., 8, 1525–1533.
940 Human Molecular Genetics, 2006, Vol. 15, No. 6
7. Wahl, G.M. (1989) The importance of circular DNA in mammalian gene
amplification. Cancer Res., 49, 1333–1340.
8. Stark, G.R., Debatisse, M., Giulotto, E. and Wahl, G.M. (1989) Recent
progress in understanding mechanisms of mammalian DNA amplification.
Cell, 57, 901–908.
9. Savelyeva, L. and Schwab, M. (2001) Amplification of oncogenes
revisited: from expression profiling to clinical application. Cancer Lett.,
167, 115–123.
10. Von Hoff, D.D. (1991) New mechanisms of gene amplification in drug
resistance (the episome model). Cancer Treat. Res., 57, 1–11.
11. Maurer, B.J., Lai, E., Hamkalo, B.A., Hood, L. and Attardi, G. (1987)
Novel submicroscopic extrachromosomal elements containing amplified
genes in human cells. Nature, 327, 434–437.
12. Slovak, M.L., Ho, J.P., Pettenati, M.J., Khan, A., Douer, D., Lal, S. and
Traweek, S.T. (1994) Localization of amplified MYC gene sequences to
double minute chromosomes in acute myelogenous leukemia. Genes
Chromosomes Cancer, 9, 62–67.
13. Streubel, B., Valent, P., Jager, U., Edelhauser, M., Wandt, H., Wagner, T.,
Buchner, T., Lechner, K. and Fonatsch, C. (2000) Amplification of the
MLL gene on double minutes, a homogeneously staining region, and ring
chromosomes in five patients with acute myeloid leukemia or
myelodysplastic syndrome. Genes Chromosomes Cancer, 27, 380–386.
14. Roijer, E., Nordkvist, A., Strom, A.K., Ryd, W., Behrendt, M.,
Bullerdiek, J., Mark, J. and Stenman, G. (2002) Translocation, deletion/
amplification, and expression of HMGIC and MDM2 in a carcinoma ex
pleomorphic adenoma. Am. J. Pathol., 160, 433–440.
15. Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A.,
Levine, R., Vermeesch, J.R., Stul, M., Dutta, B., Boeckx, N. et al. (2004)
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute
lymphoblastic leukemia. Nat. Genet., 36, 1084–1089.
16. Van Roy, N., Vandesompele, J., Menten, B., Nilsson, H., De Smet, E.,
Rocchi, M., De Paepe, A., Pahlman, S. and Speleman, F. (2006)
Translocation-excision-deletion-amplification mechanism leading to
nonsyntenic coamplification of MYC and ATBF1. Genes Chromosomes
Cancer, 45, 107–117.
17. Hunt, J.D., Valentine, M. and Tereba, A. (1990) Excision of N-myc from
chromosome 2 in human neuroblastoma cells containing amplified N-myc
sequences. Mol. Cell. Biol., 10, 823–829.
18. Feo, S., Di Liegro, C., Mangano, R., Read, M. and Fried, M. (1996) The
amplicons in HL60 cells contain novel cellular sequences linked to MYC
locus DNA. Oncogene, 13, 1521–1529.
19. Mangano, R., Piddini, E., Carramusa, L., Duhig, T., Feo, S. and Fried, M.
(1998) Chimeric amplicons containing the c-myc gene in HL60 cells.
Oncogene, 17, 2771–2777.
20. Roelofs, H., Schuuring, E., Wiegant, J., Michalides, R. and
Giphart-Gassler, M. (1993) Amplification of the 11q13 region in human
carcinoma cell lines: a mechanistic view. Genes Chromosomes Cancer, 7,
74–84.
21. Yoshida, H., Kondo, M., Ichihashi, T., Hashimoto, N., Inazawa, J.,
Ohno, R. and Naoe, T. (1998) A novel myeloid cell line, Marimo,
derived from therapy-related acute myeloid leukemia during treatment of
essential thrombocythemia: consistent chromosomal abnormalities and
temporary C-MYC gene amplification. Cancer Genet. Cytogenet., 100,
21–24.
22. Storlazzi, C.T., Fioretos, T., Paulsson, K., Strombeck, B., Lassen, C.,
Ahlgren, T., Juliusson, G., Mitelman, F., Rocchi, M. and Johansson,
B. (2004) Identification of a commonly amplified 4.3 Mb region with
over-expression of C8FW, but not MYC in MYC-containing double
minutes in myeloid malignancies. Hum. Mol. Genet., 13, 1479–1485.
23. Hyman, E., Kauraniemi, P., Hautaniemi, S., Wolf, M., Mousses, S.,
Rozenblum, E., Ringner, M., Sauter, G., Monni, O., Elkahloun, A. et al.
(2002) Impact of DNA amplification on gene expression patterns in breast
cancer. Cancer Res., 62, 6240–6245.
24. Pollack, J.R., Sorlie, T., Perou, C.M., Rees, C.A., Jeffrey, S.S.,
Lonning, P.E., Tibshirani, R., Botstein, D., Borresen-Dale, A.L. and
Brown, P.O. (2002) Microarray analysis reveals a major direct role of
DNA copy number alteration in the transcriptional program of human
breast tumors. Proc. Natl Acad. Sci. USA, 99, 12963–12968.
25. Heidenblad, M., Lindgren, D., Veltman, J.A., Jonson, T.,
Mahlamaki, E.H., Gorunova, L., van Kessel, A.G., Schoenmakers, E.F.
and Hoglund, M. (2005) Microarray analyses reveal strong influence of
DNA copy number alterations on the transcriptional patterns in pancreatic
cancer: implications for the interpretation of genomic amplifications.
Oncogene, 24, 1794–1801.
26. Brunel, V., Sainty, D., Carbuccia, N., Arnoulet, C., Costello, R.,
Mozziconacci, M.J., Simonetti, J., Coignet, L., Gabert, J.,
Stoppa, A.M. et al. (1995) Unbalanced translocation t(5;17) in an
typical acute promyelocytic leukemia. Genes Chromosomes Cancer, 14,
307–312.
27. Reddy, K.S. and Sulcova, V. (1997) c-myc amplification in a preleukemia
patient with trisomy 4 and double minutes: review of the unique
coexistence of these two chromosome abnormalities in acute
myelogenous leukemia. Cancer Genet. Cytogenet., 95, 206–209.
28. Thomas, L., Stamberg, J., Gojo, I., Ning, Y. and Rapoport, A.P. (2004)
Double minute chromosomes in monoblastic (M5) and myeloblastic (M2)
acute myeloid leukemia: two case reports and a review of literature.
Am. J. Hematol., 77, 55–61.
29. Receveur, A., Ong, J., Merlin, L., Azgui, Z., Merle-Beral, H., Berger, R.
and Nguyen-Khac, F. (2004) Trisomy 4 associated with double minute
chromosomes and MYC amplification in acute myeloblastic leukemia.
Ann. Genet., 47, 423–427.
30. Christacos, N.C., Sherman, L., Roy, A., DeAngelo, D.J. and Dal Cin, P.
(2005) Is the cryptic interstitial deletion of 8q24 surrounding MYC a
common mechanism in the formation of double minute chromosome?
Cancer Genet. Cytogenet., 161, 90–92.
31. Raghavan, M., Lillington, D.M., Skoulakis, S., Debernardi, S.,
Chaplin, T., Foot, N.J., Lister, T.A. and Young, B.D. (2005)
Genome-wide single nucleotide polymorphism analysis reveals frequent
partial uniparental disomy due to somatic recombination in acute myeloid
leukemias. Cancer Res., 65, 375–378.
32. Gorletta, T.A., Gasparini, P., D’Elios, M.M., Trubia, M., Pelicci, P.G. and
Di Fiore, P.P. (2005) Frequent loss of heterozygosity without loss of
genetic material in acute myeloid leukemia with a normal karyotype.
Genes Chromosomes Cancer, 44, 334–337.
33. Ferber, M.J., Thorland, E.C., Brink, A.A., Rapp, A.K., Phillips, L.A.,
McGovern, R., Gostout, B.S., Cheung, T.H., Chung, T.K., Fu, W.Y. et al.
(2003) Preferential integration of human papillomavirus type 18 near the
c-myc locus in cervical carcinoma. Oncogene, 22, 7233–7242.
34. Ferber, M.J., Eilers, P., Schuuring, E., Fenton, J.A., Fleuren, G.J.,
Kenter, G., Szuhai, K., Smith, D.I., Raap, A.K. and Brink, A.A. (2004)
Positioning of cervical carcinoma and Burkitt lymphoma translocation
breakpoints with respect to the human papillomavirus integration cluster
in FRA8C at 8q24.13. Cancer Genet. Cytogenet., 154, 1–9.
35. Fabris, S., Storlazzi, C.T., Baldini, L., Nobili, L., Lombardi, L.,
Maiolo, A.T., Rocchi, M. and Neri, A. (2003) Heterogeneous pattern of
chromosomal breakpoints involving the MYC locus in multiple myeloma.
Genes Chromosomes Cancer, 37, 261–269.
36. Lieber, M.R., Ma, Y., Pannicke, U. and Schwarz, K. (2003) Mechanism
and regulation of human non-homologous DNA end-joining. Nat. Rev.
Mol. Cell. Biol., 4, 712–720.
37. Rassool, F.V. (2003) DNA double strand breaks (DSB) and
non-homologous end joining (NHEJ) pathways in human leukemia.
Cancer Lett., 193, 1–9.
38. Mistry, A.R., Felix, C.A., Whitmarsh, R.J., Mason, A., Reiter, A.,
Cassinat, B., Parry, A., Walz, C., Wiemels, J.L., Segal, M.R. et al. (2005)
DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
N. Engl. J. Med., 352, 1529–1538.
39. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic
instabilities in human cancers. Nature, 396, 643–649.
40. Collis, S.J., DeWeese, T.L., Jeggo, P.A. and Parker, A.R. (2005) The life
and death of DNA-PK. Oncogene, 24, 949–961.
41. Vogt, N., Lefevre, S.H., Apiou, F., Dutrillaux, A.M., Cor, A., Leuraud, P.,
Poupon, M.F., Dutrillaux, B., Debatisse, M. and Malfoy, B. (2004)
Molecular structure of double-minute chromosomes bearing amplified
copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl
Acad. Sci. USA, 101, 11368–11373.
42. Rebuzzini, P., Khoriauli, L., Azzalin, C.M., Magnani, E., Mondello, C.
and Giulotto, E. (2005) New mammalian cellular systems to study
mutations introduced at the break site by non-homologous end-joining.
DNA Repair (Amst), 4, 546–555.
43. Saglio, G., Storlazzi, C.T., Giugliano, E., Surace, C., Anelli, L.,
Rege-Cambrin, G., Zagaria, A., Jimenez Velasco, A., Heiniger, A.,
Scaravaglio, P. et al. (2002) A 76-kb duplicon maps close to the BCR gene
on chromosome 22 and the ABL gene on chromosome 9: possible
Human Molecular Genetics, 2006, Vol. 15, No. 6 941
involvement in the genesis of the Philadelphia chromosome translocation.
Proc. Natl Acad. Sci. USA, 99, 9882–9887.
44. Barbouti, A., Stankiewicz, P., Nusbaum, C., Cuomo, C., Cook, A.,
Hoglund, M., Johansson, B., Hagemeijer, A., Park, S.S., Mitelman,
F. et al. (2004) The breakpoint region of the most common
isochromosome, i(17q), in human neoplasia is characterized by a complex
genomic architecture with large, palindromic, low-copy repeats.
Am. J. Hum. Genet., 74, 1–10.
45. Iarovaia, O.V., Shkumatov, P. and Razin, S.V. (2004) Breakpoint cluster
regions of the AML-1 and ETO genes contain MAR elements and are
preferentially associated with the nuclear matrix in proliferating HEL
cells. J. Cell Sci., 117, 4583–4590.
46. Jackson, J.A., Trevino, A.V., Herzig, M.C., Herman, T.S. and
Woynarowski, J.M. (2003) Matrix attachment region (MAR) properties
and abnormal expansion of AT island minisatellites in FRA16B fragile
sites in leukemic CEM cells. Nucleic Acids Res., 31, 6354–6364.
47. Svetlova, E.Y., Razin, S.V. and Debatisse, M. (2001) Mammalian
recombination hot spot in a DNA loop anchorage region: a model for the
study of common fragile sites. J. Cell Biochem., 81, 170–178.
48. Hensel, J.P., Gillert, E., Fey, G.H. and Marschalek, R. (2001) Breakpoints
of t(4;11) translocations in the human MLL and AF4 genes in ALL
patients are preferentially clustered outside of high-affinity matrix
attachment regions. J. Cell Biochem., 82, 299–309.
49. Sbrana, I., Zavattari, P., Barale, R. and Musio, A. (1998) Common fragile
sites on human chromosomes represent transcriptionally active regions:
evidence from camptothecin. Hum. Genet., 102, 409–414.
50. Obe, G., Pfeiffer, P., Savage, J.R., Johannes, C., Goedecke, W.,
Jeppesen, P., Natarajan, A.T., Martinez-Lopez, W., Folle, G.A. and Drets,
M.E. (2002) Chromosomal aberrations: formation, identification and
distribution. Mutat. Res., 504, 17–36.
51. Surralles, J., Sebastian, S. and Natarajan, A.T. (1997) Chromosomes with
high gene density are preferentially repaired in human cells. Mutagenesis,
12, 437–442.
52. Archidiacono, N., Antonacci, R., Marzella, R., Finelli, P., Lonoce, A. and
Rocchi, M. (1995) Comparative mapping of human alphoid sequences in
great apes using fluorescence in situ hybridization. Genomics, 25,
477–484.
53. Specchia, G., Albano, F., Anelli, L., Zagaria, A., Liso, A., Pannunzio, A.,
Archidiacono, N., Liso, V. and Rocchi, M. (2005) Molecular cytogenetic
study of instability at 1q21 approximately q32 in adult acute
lymphoblastic leukemia. Cancer Genet. Cytogenet., 156, 54–58.
54. Speicher, M.R., Gwyn Ballard, S. and Ward, D.C. (1996) Karyotyping
human chromosomes by combinatorial multi-fluor FISH. Nat. Genet., 12,
368–375.
55. Kent, W.J. (2002) BLAT-the BLAST-like alignment tool. Genome Res.,
12, 656–664.
56. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene
expression data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) method. Methods, 25, 402–408.
57. Marsano, R.M., Milano, R., Minervini, C., Moschetti, R., Caggese, C.,
Barsanti, P. and Caizzi, R. (2003) Organization and possible origin of the
Bari-1 cluster in the heterochromatic h39 region of Drosophila
melanogaster. Genetica, 117, 281–289.
58. Sambrook, J. and Russell, D. (2001) Molecular cloning: A Laboratory
Manual. 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, New York.
59. Choudhuri, J.V., Schleiermacher, C., Kurtz, S. and Giegerich, R. (2004)
GenAlyzer: interactive visualization of sequence similarities between
entire genomes. Bioinformatics, 20, 1964–1965.
942 Human Molecular Genetics, 2006, Vol. 15, No. 6
